Works matching IS 14248247 AND DT 2024 AND VI 17 AND IP 3

Results: 138
    1
    2
    3
    4
    5
    6
    7
    8

    Target Development towards First Production of High-Molar- Activity 44g Sc and 47 Sc by Mass Separation at CERN-MEDICIS.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 390, doi. 10.3390/ph17030390
    By:
    • Mamis, Edgars;
    • Duchemin, Charlotte;
    • Berlin, Valentina;
    • Bernerd, Cyril;
    • Bovigny, Mathieu;
    • Chevallay, Eric;
    • Crepieux, Bernard;
    • Gadelshin, Vadim Maratovich;
    • Heinke, Reinhard;
    • Hernandez, Ronaldo Mendez;
    • Johnson, Jake David;
    • Kalniņa, Patrīcija;
    • Koliatos, Alexandros;
    • Lambert, Laura;
    • Rossel, Ralf Erik;
    • Rothe, Sebastian;
    • Thiboud, Julien;
    • Weber, Felix;
    • Wendt, Klaus;
    • Zabolockis, Rudolfs Jānis
    Publication type:
    Article
    9
    10
    11
    12

    Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-β Production through Its Interaction with A 2A R/A 2B R.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 397, doi. 10.3390/ph17030397
    By:
    • García-Rocha, Rosario;
    • Monroy-García, Alberto;
    • Vázquez-Cruz, Ana Luisa;
    • Marín-Aquino, Luis Antonio;
    • Weiss-Steider, Benny;
    • Hernández-Montes, Jorge;
    • Don-López, Christian Azucena;
    • Molina-Castillo, Gabriela;
    • Mora-García, María de Lourdes
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Exploring the Therapeutic Potential of Ammodaucus leucotrichus Seed Extracts: A Multi-Faceted Analysis of Phytochemical Composition, Anti-Inflammatory Efficacy, Predictive Anti-Arthritic Properties, and Molecular Docking Insights.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 385, doi. 10.3390/ph17030385
    By:
    • Djehiche, Cheima;
    • Benzidane, Nadia;
    • Djeghim, Hanene;
    • Tebboub, Mehdi;
    • Mokrani, El Hassen;
    • Mebrek, Saad;
    • Messaoudi, Mohammed;
    • Bensouici, Chawki;
    • Alsalme, Ali;
    • Cornu, David;
    • Bechelany, Mikhael;
    • Arrar, Lekhmici;
    • Barhoum, Ahmed
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 374, doi. 10.3390/ph17030374
    By:
    • Alobaid, Shatha M.;
    • Alshahrani, Rahaf M.;
    • Alonazi, Asma S.;
    • Alrasheed, Nawal M.;
    • Alamin, Maha A.;
    • Alshammari, Tahani K.;
    • Bin Dayel, Anfal F.;
    • Elnagar, Doaa M.;
    • Alotaibi, Rana R.;
    • Almuthnabi, Lama A.;
    • Almasud, Dalia H.;
    • Al-Ammar, Shahad E.;
    • Almadhi, Shahad O.;
    • Almalke, Reema A.;
    • Aldamri, Nouf T.;
    • Alghibiwi, Hanan K.;
    • Alkhelb, Dalal A.;
    • Alrasheed, Nouf M.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives.

    Published in:
    Pharmaceuticals (14248247), 2024, v. 17, n. 3, p. 354, doi. 10.3390/ph17030354
    By:
    • Bracigliano, Alessandra;
    • Marretta, Antonella Lucia;
    • Guerrera, Luigi Pio;
    • Simioli, Roberto;
    • Clemente, Ottavia;
    • Granata, Vincenza;
    • Minopoli, Anita;
    • Della Vittoria Scarpati, Giuseppina;
    • Picozzi, Fernanda;
    • Cannella, Lucia;
    • Pizzolorusso, Antonio;
    • Di Gennaro, Francesca;
    • Tafuto, Roberto;
    • Sarno, Maria Rosaria;
    • Cavalcanti, Ernesta;
    • Ribera, Dario;
    • Tafuto, Salvatore
    Publication type:
    Article